Autonomix Medical to Showcase Long-Term Pain Mitigation Results in Pancreatic Cancer at SIR 2026

Autonomix Medical's abstract on long-term pain mitigation in pancreatic cancer has been selected for a Featured Abstract presentation at the Society of Interventional Radiology 2026 Annual Scientific Meeting. The study evaluates the effectiveness of denervation using transvascular radiofrequency energy-based ablation in patients with pancreatic adenocarcinoma. The presentation will be delivered by Dr. Lindsay Machan on April 12. The abstract highlights the importance of addressing cancer-related pain and the potential of Autonomix's technology to offer a new therapeutic option for pain management.